Müller B, Schmidtke M
Cardiovascular Pharmacology, Research Laboratories of Schering AG, Berlin (West), Federal Republic of Germany.
Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:455-8.
In the hamster cheek pouch, microvascular effects of iloprost at a nonhypotensive dose include vasodilatation at the level of arterioles and venules without changes in microvascular permeability, increased number of perfused capillaries/cm2, prevention of microvascular spasm and capillary ischemia as caused by LTD4, and inhibition of histamine- and 5-HT-induced venular leakage of FITC-dextrane. As regards the effects on basal vessel tone, capillary density, and prevention of LTD4 effects, PGE1 had similar effects as also shown by others in the human cutaneous microcirculation. However, PGE1 did not prevent the microvascular leakage caused by histamine. The Ca2+-antagonist nifedipine, apart from arteriolar vasodilatation, neither increased venular diameter and capillary perfusion nor prevented the effects of LTD4 and histamine. The microvascular actions of iloprost by improvement of tissue perfusion and prevention of mediator-induced tissue edema and vasospasm could contribute to the beneficial effects observed in ischemic diseases.
在仓鼠颊囊中,依洛前列素在非降压剂量下的微血管效应包括小动脉和小静脉水平的血管舒张,而微血管通透性无变化,每平方厘米灌注毛细血管数量增加,预防由白三烯D4引起的微血管痉挛和毛细血管缺血,以及抑制组胺和5-羟色胺诱导的FITC-葡聚糖的小静脉渗漏。关于对基础血管张力、毛细血管密度的影响以及对白三烯D4效应的预防,前列腺素E1具有类似的作用,其他人在人体皮肤微循环中也有类似发现。然而,前列腺素E1不能预防组胺引起的微血管渗漏。钙拮抗剂硝苯地平,除了使小动脉血管舒张外,既不增加小静脉直径和毛细血管灌注,也不能预防白三烯D4和组胺的作用。依洛前列素通过改善组织灌注以及预防介质诱导的组织水肿和血管痉挛所产生的微血管作用,可能有助于在缺血性疾病中观察到的有益效果。